Author

Monica Rossin

University of Trieste

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Davide SelvestreliD· 1 shared Licio CollaviniD· 1 shared Luca BragaiD· 1 shared Luca L. FavaiD· 1 shared Maria Chiara MatteviiD· 1 shared Raffaella KlimaiD· 1 shared Rossella De Florian FaniaiD· 1 shared Sabrina GhettiiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Davide SelvestrelORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Drug-repurposing screen identifies thiostrepton as a novel regulator of the tumor suppressor DAB2IP

Rossella De Florian Fania, Serena Maiocchi, Raffaella Klima, Monica Rossin, Valeria Pellegrini, Sabrina Ghetti, Davide Selvestrel, Maria Chiara Mattevi, Luca L. Fava, Luca Braga, Licio Collavin

The paper screens FDA-approved drugs to find those that increase DAB2IP protein levels, identifying thiostrepton as a potential anti-cancer agent that relies on DAB2IP for its tumor-suppressive effect.

Biomolecules · Aug 8, 2025Peer-reviewedCancer Biology